Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects

Clinical trial NCT00741819 · COMPLETED

Trial details

NCT number: NCT00741819
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2008-09-01
Primary completion: 2010-03-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.